日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Multimodal Assessment of Biological Age Following Radiation Therapy Among Patients With Early-Stage NSCLC

早期非小细胞肺癌患者放疗后生物年龄的多模式评估

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2026.4872
Lee, Grace; Haugg, Fridolin; Bontempi, Dennis; He, John; Bitterman, Danielle S; Pai, Suraj; Guthier, Christian; Fitzgerald, Kelly J; Kozono, David E; Kann, Benjamin H; Aerts, Hugo J W L; Mak, Raymond H
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Stereotactic Body Radiation Therapy With Pembrolizumab in Programmed Cell Death Protein 1 Inhibitor-Refractory Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial

帕博利珠单抗联合立体定向放射治疗治疗程序性细胞死亡蛋白1抑制剂难治性复发或转移性头颈部鳞状细胞癌：一项II期试验

期刊:International Journal of Radiation Oncology Biology Physics
影响因子:6.5
doi:10.1016/j.ijrobp.2025.12.043
So, Jonathan; Droznin, Alexander D; Tiwari, Payal; Chen, Yu-Hui; Chau, Nicole G; Margalit, Danielle N; Tishler, Roy B; Hanna, Glenn J; Mak, Raymond H; Fitzgerald, Kelly J; Sehgal, Kartik; Li, Shuqiang; Gunasti, Lauren; Kim, Emily; Minken, Jacqueline; Baginska, Joanna; Nau, Allison; Diaz, Ilana Gomez; Shim, Bohoon; Janes, John Thomas 3rd; Uppaluri, Ravindra; Haddad, Robert I; Livak, Kenneth J; Schoenfeld, Jonathan D
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation

探索已发表的和新型的治疗前CT和PET放射组学数据，以对接受立体定向放射治疗的早期非小细胞肺癌患者的疾病进展风险进行分层

期刊:Radiotherapy and Oncology
影响因子:5.3
doi:10.1016/j.radonc.2023.109983
Thor, Maria; Fitzgerald, Kelly; Apte, Aditya; Oh, Jung Hun; Iyer, Aditi; Odiase, Otasowie; Nadeem, Saad; Yorke, Ellen D; Chaft, Jamie; Wu, Abraham J; Offin, Michael; Simone II, Charles B; Preeshagul, Isabel; Gelblum, Daphna Y; Gomez, Daniel; Deasy, Joseph O; Rimner, Andreas
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Genomic ancestry in kidney cancer: Correlations with clinical and molecular features

肾癌的基因组祖先：与临床和分子特征的相关性

期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.35074
Kotecha, Ritesh R; Knezevic, Andrea; Arora, Kanika; Bandlamudi, Chaitanya; Kuo, Fengshen; Carlo, Maria I; Fitzgerald, Kelly N; Feldman, Darren R; Shah, Neil J; Reznik, Ed; Hakimi, A Ari; Carrot-Zhang, Jian; Mandelker, Diana; Berger, Michael; Lee, Chung-Han; Motzer, Robert J; Voss, Martin H
肿瘤
肾癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Edge roughness quantifies impact of physician variation on training and performance of deep learning auto-segmentation models for the esophagus

边缘粗糙度量化了医生操作差异对食管深度学习自动分割模型训练和性能的影响

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-023-50382-z
Yan, Yujie; Kehayias, Christopher; He, John; Aerts, Hugo J W L; Fitzgerald, Kelly J; Kann, Benjamin H; Kozono, David E; Guthier, Christian V; Mak, Raymond H
发表日期：2024
文献求助 收藏

Delta radiomics to track radiation response in lung tumors receiving stereotactic magnetic resonance-guided radiotherapy

Delta放射组学用于追踪接受立体定向磁共振引导放射治疗的肺肿瘤的放射反应

期刊:Physics and Imaging in Radiation Oncology
影响因子:3.3
doi:10.1016/j.phro.2024.100626
Zha, Yining; Ye, Zezhong; Zapaishchykova, Anna; He, John; Hsu, Shu-Hui; Leeman, Jonathan E; Fitzgerald, Kelly J; Kozono, David E; Mak, Raymond H; Aerts, Hugo J W L; Kann, Benjamin H
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial

卡博替尼联合纳武利尤单抗治疗非透明细胞肾细胞癌患者：一项 II 期试验的最新结果

期刊:
影响因子:
doi:10.1016/j.eururo.2024.04.025
Fitzgerald, Kelly N; Lee, Chung-Han; Voss, Martin H; Carlo, Maria I; Knezevic, Andrea; Peralta, Laura; Chen, Yingbei; Lefkowitz, Robert A; Shah, Neil J; Owens, Colette N; McHugh, Deaglan J; Aggen, David H; Laccetti, Andrew L; Kotecha, Ritesh R; Feldman, Darren R; Motzer, Robert J
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2024
文献求助 收藏

Adjuvant therapy options in renal cell carcinoma - targeting the metastatic cascade

肾细胞癌辅助治疗方案——靶向转移级联反应

期刊:Nature Reviews Urology
影响因子:14.6
doi:10.1038/s41585-022-00666-2
Fitzgerald, Kelly N; Motzer, Robert J; Lee, Chung-Han
肿瘤
肿瘤免疫
信号转导
肾癌
细胞生物学
发表日期：2023
文献求助 收藏

Amplification of Wild-Type RET Represents a Novel Molecular Subtype of Several Cancer Types With Clinical Response to Selpercatinib

野生型RET扩增代表了多种癌症类型的一种新型分子亚型，这些癌症对Selpercatinib有临床反应。

期刊:Jco Precision Oncology
影响因子:5.6
doi:10.1200/PO.23.00295
Gandhi, Malini M; Ricciuti, Biagio; Harada, Guilherme; Repetto, Matteo; Gildenberg, Melissa S; Singh, Ankit; Li, Yvonne Y; Gagné, Andréanne; Wang, Xinan; Aizer, Ayal; Fitzgerald, Kelly; Nishino, Mizuki; Alessi, Joao; Pecci, Federica; Di Federico, Alessandro; Fisch, Adam; Drilon, Alexander; Nardi, Valentina; Sholl, Lynette; Awad, Mark M; Rotow, Julia
肿瘤
肿瘤免疫
RET
发表日期：2023
文献求助 收藏

Pneumonitis in Patients Receiving Thoracic Radiotherapy and Osimertinib: A Multi-Institutional Study

接受胸部放疗和奥希替尼治疗的患者发生肺炎：一项多中心研究

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2023.100559
Banla, Leou Ismael; Tzeng, Alice; Baillieul, John P; Kandekhar, Melin J; Fitzgerald, Kelly J; LoPiccolo, Jaclyn; Poitras, Holly A; Soto, Daniel E; Rotow, Julia K; Singer, Lisa; Willers, Henning; Kozono, David E; Janne, Pasi A; Mak, Raymond H; Piotrowska, Zofia; Keane, Florence K; Kann, Benjamin H
肺炎
发表日期：2023
文献求助 收藏